Онкоурология №4 2011

2011

ISSN 1726-9776

4 - ,

-

,

-

!

c ! ,

, !

, , ..

- 1,2

1,2

-:

- 3

(0,5 )4

- - 3

PDS-( )

() : N015554/01 04.05.2010 . -: 3,75 . : 3,75 . : ( ), .. - . ( 6 - ). ( 6 , - , ). . () - . : , - , . . - . . . ( - ). 65 . : . - . : , , , , , , - , -, , , , , , . - , , . . : . ., , , .

1. W. Bischoff 3.75 mg and 7.5 mg leuprorelin acetate depot in the treatment of advanced Prostatic Cancer: Preliminary Report. Journal of International Medical Research 1990; 18 (Suppl. 1), p. 103 -113.2. Mazzei T. et al. Drugs Exptl Clin Res 1989; 15(8); 373-387. : 3.75 mg, 7.5 mg, 15 mg & 30 mg.3. .4. Abbott CMS File for Lucrin depo. 3.2.P.7. Container Closure System.

115114 , . , , .11 .: (495) 258-42-70. : (495) 258-42-71www.abbott.com

PR-R

U-A

BB-LUC-7

2(09

/11)

GlaxoSmithKline: 121614, . , . , . 17, - , . 3, 5 . : (495) 777-89-00; : (495) 777-89-01

() () 200 400 , . - , 200 400 , .: - . : , . ( 1 - 2 ) 800 . , . 200 , 800 . : < 30 / . : - 200 ; . (

-

: ..

. , , - . , . , , - , .

? , , , - +7 (499) 929-96-19 e-mail: book@abvpress.ru., : . , , 24, 15, , 3- , -. -: www.abvpress.ru

: 170 x 220 .: .

e: 220 . : .

,

-

. . , .,

. . ..

-. , . ..

. . , . ..

-. , . ..

. . , . ..

. . , . ..

. . , .

.. ()

. . , .

.. ()

. . .. ()

. . , . .. ()

. . , . .. ()

. . , . .. ()

. . , . .. ()

. . , . .. ()

. . , . .. ()

. . .. (.-)

. . , . .. (--)

. . .. ()

. . , . .. ()

. . , . .. (.-)

. . , . .. (.-)

. . .. ()

. . , . .. ()

. . , . .. ()

. . .. ()

. . , . .. ()

EDITOR-IN-CHIEF

B.P. Matveev, MD, DMSci, Prof.,

Honored Scientist of the Russian Federation

DEPUTIES EDITOR-IN-CHIEF

Yu.G. Alyaev, MD, Prof., RAMSci Corr. Mem.

O.B. Karyakin, MD, DMSci, Prof.

O.B. Loran, MD, Prof., RAMSci Corr. Mem.

I.G. Rusakov, MD, DMSci, Prof.

EXECUTIVE EDITOR

B.Ya. Alekseev, MD, DMSci, Prof.

EDITORS FROM CIS COUNTRIES

A.S. Pereverzev, MD, DMSci, Prof.

(Ukraine)

O.G. Sukonko, MD, DMSci, Prof.

(Belarus)

EDITORIAL BOARD

B.V. Bukharkin, MD, DMSci (Moscow)

E.I. Veliev, MD, DMSci, Prof. (Moscow)

A.Z. Vinarov, MD, DMSci, Prof. (Moscow)

R.Kh. Galeev, MD, DMSci, Prof. (Kazan)

S.P. Darenkov, MD, DMSci, Prof. (Moscow)

A.V. Zyryanov, MD, DMSci, Prof. (Yekaterinburg)

A.D. Kaprin, MD, DMSci, Prof. (Moscow)

P.A. Karlov, MD, CMSci (Saint Petersburg)

M.I. Kogan, MD, DMSci, Prof. (Rostov-on-Don)

V.O. Mager, MD, CMSci (Yekaterinburg)

V.B. Matveev, MD, DMSci, Prof. (Moscow)

V.M. Moiseenko, MD, DMSci, Prof. (Saint Petersburg)

S.B. Petrov, MD, DMSci, Prof. (Saint Petersburg)

A.N. Ponukalin, MD, CMSci (Saratov)

S.A. Tjulandin, MD, DMSci, Prof. (Moscow)

K.M. Figurin, MD, DMSci, Prof. (Moscow)

Yu.N. Khrisman, MD, CMSci (Ufa)

L.V. Shaplygin, MD, DMSci, Prof. (Moscow)

11 : 115478 , , . 24, .15, , 3- ../: +7 (499) 929-96-19www.abvpress.rue-mail: abv@abvpress.ru

: 115478, , . 24, . .. e-mail: roou@roou.ru

.. - ... ..

.. .. ..

.. , +7 (499) 929-96-19,baza@abvpress.ru .. , +7 (499) 929-96-19,gm@abvpress.ru

, () 77-36986 21 2009 .

.

.

, .

ISSN 1726-9776. 2011. 4. 1100

-, 2011 42169

.: +7 (495) 917-82-25

4000 .

4

.. , .. . . . . . . . . . . . . . . . . . . . . . . .12

.. , .. , .. - . . . . . . . . .16

.. , .. , .. , .. , .. , .. , .. , .. , ..

. . . . . . . . . . . . . . . .21

.. , .. , .. , .. , .. , .. , .

- , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .24

.. , .. , .. , .. , .. , .. - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32

.. , .. - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37

.. , .. , .. , .. , .. , .. , .. , .. , ..

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42

.. , .. , .. , .. , ..

. . . . . . . . . . . . . . . . . . . . . . . . . . . . .47

.. , .. , .. , .. , .. , .. , .. - , . . . . . . . . . 50

.. , .. , .. , .. , .. , .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54

.. , .. , .. , .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59

.. , .. , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67

.. , .. - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .71

.. , .. , .. , .. , .. , ..

( ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74

.. , .. , .. - ( ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77

.. , .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81

.. , .. , .. , .. , .. , .. , ..

in situ (FISH) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96

C O N T E N T S

LECTURE

B.Ya. Alekseyev, K.M. NyushkoIntermittent hormone therapy in patients with prostate cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS

Renal cancer

M.I. Kogan, A.A. Gusev, S.V. EvseyevEvaluation of renal function in patients with renal cell carcinoma before and after radical nephrectomy . . . . . . . . . . . . . .16

T.M. Cherdantseva, I.P. Bobrov, V.V. Klimachev, V.M. Bryukhanov, A.F. Lazarev, A.M. Avdalyan, V.Ya. Gervald, A.Yu. Dolgatov, V.A. Popov

Tumor angiogenesis in the peritumor area in kidney cancer patients: clinical aspects . . . . . . . . . . . . . . . . . . . . . . . . . . . .21

M.V. Peters, V.E. Shevchenko, V.B. Matveev, M.I. Volkova, S.A. Kalinin, D.M. Mikhailenko, D.V. Zaletayev

Prognostic value of molecular genetic markers in kidney cancer patients receiving targeted therapy. . . . . . . . . . . . . . . . .24

Urinary bladder and upper urinary tract cancer

T.I. Shabunina, S.P. Selivanov, A.A. Kladiyev, E.V. Barisheva, T.A. Kovalik, S.N. IsayevaComparative analysis of the therapeutic efficacy of prospidine and cisplatin in neoadjuvant intravesicular chemotherapy for non-muscle invasive bladder cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32

A.V. Semenov, A.A. KosulinaRepeat transurethral resection of the bladder and the results of treatment in patients with non-muscle invasive bladder cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37

L.D. Roman, L.A. Vasilyev, A.Yu. Shestayev, V.Kh. Kheifets, I.P. Kostyuk, K.G. Shostka, A.N. Pavlenko, S.S. Krestyaninov, O.F. Kagan

Choice of a procedure for formation of ureteroileal anastomosis during Bricker urine derivation in elderly and senile patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42

M.N. Tillyashaikhov, N.Sh. Yuldasheva, D.K. Abdurakhmonov, D.A. Ryabchikov, E.V. Kolesnikova

Different types of urine derivation after small pelvic evisceration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47

Prostate cancer

Z.N. Shavladze, T.P. Berezovskaya, E.A. Petrova, O.B. Karyakin, D.V. Neledov, N.A. Gorban, A.O. KaryakinResults of preoperative detection of locally advanced prostate cancer in patients undergoing radical prostatectomy . . . . .50

C O N T E N T S

A.V. Petrovsky, B.V. Bukharkin, V.N. Sholokhov, D.A. Roshchin, V.B. Matveyev, M.I. Nechushkin

Analysis of complications due to intratissue radiotherapy using constant sources in patients with prostate cancer. . . . . . .54

P.D. Demeshko, A.V. Karman, O.G. Sukonko, S.A. Krasny

Prognostic factors of positive results of multifocal trus-guided vesicouret